Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia.

B-cell chronic lymphocytic leukemia (B-CLL) is a slowly progressive disease characterized by the clonal expansion of CD5+/CD23+ B lymphocytes. The malignant transformation is assumed to occur at the level of mature B lymphocytes. We asked whether CD34+ progenitor cells are involved in the malignant process in B-CLL. Furthermore, we investigated the possibility of aberrant CD34 expression by the malignant B-cell clone. Bone marrow and peripheral blood samples from 75 patients with B-CLL were tested for the presence of trisomy 12 and deletion of the retinoblastoma gene (Rb) by fluorescence in situ hybridization. CD34+ subpopulations were isolated by fluorescence-activated cell sorting and analyzed for the presence of the informative genetic marker. Bone marrow and peripheral blood samples of 10 B-CLL patients were analyzed for coexpression of CD34/CD5/CD20. Trisomy 12 was detected in 15 of 75 (20%) and Rb-deletion was detected in 6 of 30 patients (20%). In 7 patients with trisomy 12, hematopoietic progenitor cells were sorted, with the sort purity being between 85% and 99.8%. The genetic marker was detected in the CD34+/CD38+ cells as well as in the CD34+/38- subsets in 3 patients. Progenitor cells were also sorted in 2 patients with Rb-deletion. In 1 patient, Rb-deletion was present in 10% of CD34+/38+ cells. In the other patient, Rb-deletion was neither detected in the CD34+/38+ nor in the CD34+/CD38- subsets. In all 10 patients investigated for coexpression of CD34/CD5/CD20, we could not find a subpopulation coexpressing these markers. We conclude that trisomy 12 and Rb-deletion are present in a considerable subset of patients with B-CLL. In part of these patients, the genetic marker was detected at the level of CD34+ stem cells. CD34 expression is not related to an aberrant phenotype of the malignant B-cell clone. These results suggest that the malignant transformation in B-CLL may involve early hematopoietic stem cells and place a note of caution on future strategies using autologous stem cell transplantation.

[1]  J. Gribben,et al.  Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. , 1996, Blood.

[2]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[3]  E. Montserrat,et al.  HLA-Identical Sibling Bone Marrow Transplantation in Younger Patients with Chronic Lymphocytic Leukemia , 1996, Annals of Internal Medicine.

[4]  D. Catovsky,et al.  Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients , 1996, British journal of haematology.

[5]  M. Fackler,et al.  CD34: structure, biology, and clinical utility. , 1996, Blood.

[6]  W. Hiddemann,et al.  Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations , 1995 .

[7]  M. Slovak,et al.  Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. , 1995, Blood.

[8]  C. Verfaillie,et al.  CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells. , 1994, Blood.

[9]  H. Stein,et al.  Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. , 1994, Blood.

[10]  C. Mecucci,et al.  Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias , 1994, British journal of haematology.

[11]  D. Oscier.  Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia. , 1994, Blood reviews.

[12]  D. Catovsky,et al.  Trisomy 12 in B‐cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization , 1994, British journal of haematology.

[13]  B. Andersson,et al.  Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[15]  C. Verfaillie,et al.  Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro , 1994, The Journal of experimental medicine.

[16]  H. Döhner,et al.  Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias. , 1994, Leukemia & lymphoma.

[17]  K. Cornetta,et al.  Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. , 1993, Blood.

[18]  D. Catovsky,et al.  Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. , 1993, Blood.

[19]  M. Andreeff,et al.  Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. , 1993, Blood.

[20]  H. Döhner,et al.  High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics , 1993 .

[21]  R. Berger,et al.  Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. , 1993, Leukemia.

[22]  W. Hiddemann,et al.  Detection of aberrant antigen expression in acute myeloid leukemia by multiparameter flow cytometry. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[23]  O. Majdic,et al.  Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c‐kit , 1992, British journal of haematology.

[24]  J. Rowley,et al.  Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. , 1992, Blood.

[25]  J. Dick,et al.  Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. , 1992, Science.

[26]  A. Kantor.  The development and repertoire of B-1 cells (CD5 B cells). , 1991, Immunology today.

[27]  T. Kipps,et al.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes. , 1991, The Journal of clinical investigation.

[28]  P. Lansdorp,et al.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. , 1991, Blood.

[29]  K. Rajewsky,et al.  B cells of chronic lymphatic leukemia express V genes in unmutated form. , 1991, Leukemia research.

[30]  S. Knuutila,et al.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. , 1990, The New England journal of medicine.

[31]  L. Terstappen,et al.  Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. , 1990, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[32]  C. Grossi,et al.  Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. , 1987, Blood.

[33]  M R Loken,et al.  Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. , 1987, Blood.

[34]  A. de la Chapelle,et al.  Trisomy 12 in B cells of patients with B-cell chronic lymphocytic leukemia. , 1986, The New England journal of medicine.

[35]  M. Gobbi,et al.  Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia , 1982, The Journal of experimental medicine.

[36]  J. Dausset,et al.  Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells , 1978, European journal of immunology.

[37]  T. Papayannopoulou,et al.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.